S.Africa, Swiss firm Lonza in $211 mln drug JV
2/10/2012
JOHANNESBURG - South Africa will set up a $211 million joint venture with Swiss firm Lonza Group to manufacture the main chemicals used in HIV drugs, a senior conclusive said on Friday, as part of a guidance plan to lower prices of criti...
More: - Read More
Post Comment
Entry 1 of 16100
Last Page | Next Page









